The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial

10.1016/j.trci.2018.12.001

Saved in:
Bibliographic Details
Main Authors: Chen, C.L.H., Sharma, P.R., Tan, B.Y., Low, C., Venketasubramanian, N.
Other Authors: PHARMACOLOGY
Format: Article
Published: Elsevier Inc 2021
Subjects:
Alzheimer's disease
Clinical trial
Disease progression
MLC901
Neuroaid II
Online Access:https://scholarbank.nus.edu.sg/handle/10635/212354
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1016/j.trci.2018.12.001

Similar Items